Back to Results
First PageMeta Content
Clinical research / Drug discovery / Food and Drug Administration / Research exemption / Merck KGaA v. Integra Lifesciences I / Ltd. / Drug Price Competition and Patent Term Restoration Act / Generic drug / New Drug Application / Safe harbor / Pharmaceutical sciences / Pharmaceutical industry / Pharmacology


Document Date: 2013-03-31 21:19:46

Open Document

File Size: 251,71 KB

Share Result on Facebook

Company

Merck & Co. / Eli Lilly / Ventritex Co. / Bristol-Myers Squibb Co. / ALM Properties Inc. / Integra Lifesciences I Ltd. / Merck KGaA / Medtronic / Cognizant / Intermedics Inc. / Rhone-Poulenc Rorer Inc. / Stearns-Roger Mfg. / Integra Lifesciences Ltd. / /

Country

United States / /

Event

FDA Phase / Legal Issues / /

Facility

HatchWaxman Safe Harbor / Hatch-Waxman Safe Harbor / /

IndustryTerm

veterinary biological products / patentees owning biotechnology research tools / generic drug applications / pharmaceutical / law research exemption / Web address / treatment for cancer / research tools / biological research tools / /

MedicalCondition

cancer / /

Organization

Bush administration / Congress / U.S. Supreme Court / U.S. Court of Appeals / UN Court / US Federal Reserve / FDA / /

Person

JOHN D. CARLIN / Cella / Antonin Scalia / SER V H NC / Pauline Newman / Randall Rader / D. Carlin Colin / COLIN G. CABRAL / /

/

Position

Solicitor General / Harper / Judge / /

Product

Investigatory New Drug / patented / EMD / /

ProvinceOrState

Indiana / /

PublishedMedium

the NEW YORK LAW JOURNAL / /

Technology

biotechnology / pharmacokinetics / ASIC / drug development / /

URL

http /

SocialTag